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Human cytomegalovirus (HCMV) lacking TRS1 and IRS1 (HCMV[ΔI/ΔT]) cannot replicate in cell culture.
Although both proteins can block the protein kinase R (PKR) pathway, they have multiple other activities
and binding partners. It remains unknown which functions are essential for HCMV replication. To
investigate this issue, we ﬁrst identiﬁed a TRS1 mutant that is unable to bind to PKR. Like HCMV[ΔI/ΔT],
a recombinant HCMV containing this mutant (HCMV[TRS1-Mut 1]) did not replicate in wild-type cells.
However, HCMV[ΔI/ΔT] did replicate in cells in which PKR expression was reduced by RNA interference.
Moreover, HCMV[ΔI/ΔT] and HCMV[TRS1-Mut 1] replicated to similar levels as virus containing wild-
type TRS1 in cell lines in which PKR expression was knocked out by CRISPR/Cas9-mediated genome
editing. These results demonstrate that the sole essential function of TRS1 is to antagonize PKR and that
its other activities do not substantially enhance HCMV replication, at least in cultured human ﬁbroblasts.
& 2015 Elsevier Inc. All rights reserved.Introduction
Host cells express a gauntlet of intrinsic defense mechanisms
that sense and impede viral replication. One of these relies on
protein kinase R (PKR), which is activated by binding to double-
stranded RNA (dsRNA), dimerization, and autophosphorylation.
Activated PKR phosphorylates the alpha subunit of eukaryotic
initiation factor 2 (eIF2α), which in turn blocks the guanine
nucleotide exchange factor eIF2B from replenishing the supply of
eIF2α-tRNAMet-GTP ternary complex that is necessary for transla-
tion initiation (Dever et al., 2007). The resulting shutdown of
protein synthesis is one tactic that host cells use to prevent viruses
from replicating.
Many viruses encode at least one antagonist of the PKR path-
way (Mohr et al., 2007). Human cytomegalovirus (HCMV) encodes
two highly similar proteins, TRS1 and IRS1, each of which is able to
inhibit the PKR pathway (Child et al., 2004). Infection of cells with
a viral mutant lacking both genes (HCMV[ΔI/ΔT]) shuts off host
protein synthesis and causes an increase in the level of phos-
pho-eIF2α, indicating that the PKR pathway has been activatedlogy Fred Hutchinson Cancer
3, Seattle, WA 98109-1024.
schild@fhcrc.org (S.J. Child),(Marshall et al., 2009). Unlike single mutant viruses that lack
either TRS1 or IRS1, HCMV[ΔI/ΔT] does not replicate in cell cul-
ture (Blankenship and Shenk, 2002; Dunn et al., 2003; Jones and
Muzithras, 1992; Marshall et al., 2009). These observations suggest
that PKR pathway inhibition may be the essential role of TRS1 or
IRS1 in HCMV replication. However, TRS1 and IRS1 have been
reported to have several additional functions, one or more of
which might be essential for viral replication. Both proteins have
been reported to bind to Beclin 1 and inhibit autophagy (Chau-
morcel et al., 2012; Mouna et al., 2015), to block the 20-50 oligoa-
denylate synthetase (OAS)/RNaseL pathway (Child et al., 2004),
and to have potential roles as transcriptional activators (Roma-
nowski and Shenk, 1997; Stasiak and Mocarski, 1992). The IRS1
gene has also been reported to encode a second product that acts
as a transcriptional repressor (Romanowski and Shenk, 1997).
Additional studies focusing on TRS1 have shown that it binds to
the DNA polymerase accessory factor UL44 and may play a role in
virion assembly (Adamo et al., 2004; Blankenship and Shenk,
2002; Strang et al., 2010). Finally, TRS1 was recently reported to
have a role in translation stimulation following mRNA cap binding
(Ziehr et al., 2015). Thus, while TRS1 and IRS1 appear to have
multiple functions, those that are essential for HCMV replication
have not been established.
We undertook a two-pronged approach to investigate the
hypothesis that the sole essential function of TRS1 is to block the
PKR pathway. First, we identiﬁed TRS1 mutants that have lost the
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non-PKR binding TRS1 mutant (HCMV[TRS1-Mut 1]) was unable
to replicate in wild-type human ﬁbroblasts (HF). Second, we used
both RNA silencing and CRISPR gene-editing technology to reduce
or eliminate the expression of endogenous PKR in HF. We found
that HCMV[ΔI/ΔT] replication was restored in cell lines depleted
of PKR. Notably, we did not detect any major differences in the
replication of HCMV[ΔI/ΔT] compared to that of a virus expres-
sing TRS1 in PKR knockout cells. These data reveal that PKR
antagonism is the only essential function of TRS1 or IRS1, and that,
at least for the AD169 strain of HCMV, the additional activities
ascribed to TRS1 do not substantially enhance replication in HF.Results
Identiﬁcation of TRS1 mutants that are unable to bind to PKR
In order to determine the role of PKR inhibition by TRS1 in
HCMV replication, we ﬁrst sought to identify TRS1 mutants that
are unable to bind to and antagonize PKR. Previous data indicated
that a C-terminal region of TRS1 is critical for these functions
(Hakki and Geballe, 2005; Hakki et al., 2006). Building on these
prior observations, we used yeast two-hybrid assays to more
precisely delineate the region of TRS1 required for interaction
with PKR. Consistent with our previous report (Child et al., 2012),
yeast codon-optimized TRS1 bound to kinase-dead (K296R)
human PKR (Fig. 1). Progressive deletions from the TRS1 C-
terminus resulted in a gradual decrease in binding. One C-
terminal TRS1 truncation (TRS1[1-679]), which was previously
reported to not bind detectably to PKR in mammalian cell assays
(Hakki et al., 2006), exhibited considerably decreased but mea-
surable PKR binding in this assay. Further deletion of codons
following residue 667 eliminated all detectable binding.
Although these results did not deﬁne a discrete position at which
binding is eliminated, they did corroborate the importance of the
C-terminus of TRS1 for binding to PKR.
In order to generate a TRS1 mutant that fails to bind to PKR but
is expected to retain other functional interactions for which the C-
terminus is known to be dispensable (Chaumorcel et al., 2012;
Hakki and Geballe, 2005; Strang et al., 2010), we next constructed
C-terminal charged-cluster-to-alanine (CCTA) mutations. This
method, which has been used in studies of other HCMV proteins
and in other systems (Schuessler et al., 2010, 2008, 2012), capi-
talizes on the propensity for charged clusters of amino acids to be
surface-exposed. Therefore, charged clusters are likely to be
mediators of protein–protein interactions and to tolerate muta-
tions without drastically impacting the overall protein structure.
An alignment of HCMV TRS1 and IRS1 with closely related chim-
panzee CMV homologs reveals several conserved charged aminoTR
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Fig. 1. Yeast two-hybrid analysis of the interaction between PKR and TRS1. Plas-
mids expressing kinase-dead PKR fused to the GAL4 activation domain and the
indicated regions of TRS1 fused to the GAL4 binding domain or an empty vector
control were co-transformed into yeast. The strength of the protein–protein
interactions was assessed by β-galactosidase activity assays.acid clusters (Fig. 2a). We chose seven clusters that possess at least
two conserved residues within a ﬁve-residue window and engi-
neered alanine mutations at each of these positions to produce
mutants TRS1-Mut 1 through TRS1-Mut 7.
We evaluated PKR binding to these mutants by co-transfecting
plasmids that express kinase-dead PKR along with each of the
TRS1 variants into 293T cells. The S2H-tagged TRS1 proteins were
pulled down using Streptactin beads, after which bound proteins
were separated by SDS:PAGE then subjected to immunoblot ana-
lysis with an anti-PKR antibody. Expression of the His-tagged
transfected genes was also monitored by immunoblot analysis of
the cell lysates. As shown previously, wild-type TRS1 and an N-
terminal TRS1 mutant that cannot bind to dsRNA (Triple Mut) both
bound to PKR, while a C-terminal deletion mutant (TRS1[1-648])
and a GFP control plasmid did not (Fig. 2b, lanes 1–3, 11; (Bierle et
al., 2013; Hakki et al., 2006)). Several of the CCTA mutants bound
PKR (Fig. 2b, lanes 6, 8, 9, and 10), indicating that these residues
are dispensable for this activity. However, TRS1-Mut 1 did not bind
to PKR at all and TRS1-Mut 2 bound only weakly (Fig. 2b, lanes
4 and 5). Although TRS1-Mut 4 did not appear to bind to PKR, its
expression was lower that the other TRS1 variants in this and
other experiments (not shown).
These experiments identiﬁed PKR binding deﬁciencies of TRS1-
Mut 1 and TRS1-Mut 2. We expected the CCTA mutants to retain
other known TRS1 activities that have been reported to function
even when the C-terminal PKR-binding region is deleted (Chau-
morcel et al., 2012; Hakki and Geballe, 2005; Strang et al., 2010).
To test this prediction, we performed dsRNA-binding assays with
each of the CCTA mutants. Immunoblot analysis of proteins bound
to poly[I:C] beads revealed that wild-type TRS1 bound dsRNA,
while Triple Mut did not (Fig. 2c). As in past experiments, we
found considerable variation in the intensity of binding (Bierle et
al., 2013). In contrast to the negative controls, Triple Mut and GFP,
all of the CCTA mutants bound dsRNA at least to a detectable level.
The one exception was TRS1-Mut 4, which again expressed quite
poorly. These results suggest that these CCTA mutations, including
those that completely disrupt PKR binding, retained some dsRNA-
binding activity, although some of the mutants appear to bind to
dsRNA less well than the wild-type protein.PKR binding is required for VVΔE3L rescue by TRS1
Previous data showed that the C-terminal region of TRS1 that is
required for PKR binding is also required to rescue replication of
VVΔE3L, a vaccinia virus mutant lacking its own PKR antagonist,
E3L (Hakki and Geballe, 2005). Therefore, to determine more
speciﬁcally whether PKR binding is necessary for TRS1 to rescue
VVΔE3L, we tested three of our CCTA mutants. HeLa cells were
transfected with plasmids expressing TRS1-Mut 1, TRS1-Mut 2, or
TRS1-Mut 3, which bind to PKR to varying extents (Fig. 2b). After
transfection, cells were infected with VVΔE3L (MOI¼0.1) and viral
replication was measured. Wild-type TRS1 rescued VVΔE3L
replication, whereas Triple Mut, TRS1[1-648], and GFP did not
(Fig. 3), consistent with previous reports (Bierle et al., 2013; Hakki
and Geballe, 2005). TRS1-Mut 1 failed to rescue VVΔE3L, while
TRS1-Mut 2 rescued VVΔE3L to an intermediate degree and TRS1-
Mut 3 rescued to wild-type levels. TRS1-Mut 5, 6, and 7, all of
which bound to PKR as well as wild-type TRS1 did, also rescued
VVΔE3L to a level similar to wild type TRS1 (data not shown).
Thus, the ability of the mutants to rescue VVΔE3L replication
correlated well with their ability to bind PKR, supporting the
conclusion that PKR binding by TRS1 is likely important for
blocking PKR activity and enabling VVΔE3L replication.
Fig. 2. Binding properties of TRS1 charged-cluster-to-alanine mutants. (a) HCMV TRS1 and IRS1 (Towne strain) were aligned with Chimpanzee CMV TRS1 and IRS1
(Heberling strain). Clusters of two to ﬁve charged residues within ﬁve residue windows near the C-terminus were identiﬁed (highlighted in yellow). Seven of these clusters
were selected for mutation to alanine in human TRS1 (* denotes identical residues; þ indicates conserved charge in at least two other genes). (b) For PKR binding assays,
COS7 cells were co-transfected with kinase-dead PKR-BH and the indicated TRS1-S2H expression plasmids. At 48 h post-transfection, lysates were harvested and pulldown
assays performed as detailed in Materials and methods. Input samples representing 5% of each lysate (top panel) were visualized using a His antibody. Following pulldown,
bound PKR was detected by immunoblot analysis using the PKR B-10 antibody (bottom panel). (c) For dsRNA binding assays, 293T cells were transfected with the indicated
TRS1-S2H constructs or a GFP-S2H control. At 48 h post-transfection, input samples (I) and proteins that bound to poly[I:C] Sepharose beads (B) or control beads (C) were
analyzed by immunoblotting with His antibody.
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Fig. 3. PKR binding is required for VVΔE3L rescue. HeLa cells were transfected with
the indicated TRS1 constructs or a GFP control and infected with VVΔE3L
(MOI¼0.1) at 48 h post-transfection in triplicate. At 48 hpi, VVΔE3L replication was
measured by β-galactosidase activity assay (top panel). Expression of TRS1 (and
actin as a loading control) was monitored by immunoblot assay (bottom panel).
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Although these data suggest that the ability of TRS1 to bind
PKR is required for rescue of VVΔE3L, the importance of PKRbinding and inhibition by TRS1 during HCMV infection has not yet
been tested. Therefore, we constructed recombinant HCMVs
expressing wild-type TRS1 or TRS1-Mut 1 as described in Mate-
rials and methods. The expected structures of the BAC DNAs were
veriﬁed by restriction enzyme digestion (Fig. 4a). We reconstituted
each virus by transfection into HF-TRS1. The correct location and
identity of the TRS1 gene in each of the reconstituted viruses was
conﬁrmed by PCR using primers external to the TRS1 locus
(Fig. 4b) and sequencing (data not shown). TRS1 protein expres-
sion following infection of HF-TRS1 cells (which express very low
amounts of TRS1) was detectable from all viruses, with the
exception of HCMV[ΔI/ΔT] (Fig. 4c).
To examine whether PKR binding by TRS1 is necessary for
HCMV replication, we infected HF with each virus and measured
the amount of virus produced in cell supernatants by titering on
HF-TRS1 (Fig. 5a). AD169 and HCMV[TRS1-S2H] replicated in HF,
while HCMV[ΔI/ΔT] did not, consistent with previous results
(Marshall et al., 2009). We did not detect any HCMV[TRS1-Mut 1]
replication in HF (Fig. 5a). A second HCMV mutant containing
TRS1-Mut 1 also failed to replicate at all in HF (data not shown),
supporting the conclusion that the replication defect in HCMV
[TRS1-Mut 1] is due to the TRS1-Mut 1 and not to another
mutation elsewhere in the genome. Although these data do not
exclude the possibility that the mutations in TRS1-Mut 1 also
weaken another TRS1 function for which the C-terminal region is
not absolutely required, they do suggest that PKR binding by TRS1
is most likely necessary for HCMV replication.
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separated on agarose gels. Arrowheads point to bands expected to differ between the BACs. (b) Primers external to the homology arms used for recombination into the
HCMV[ΔI/ΔT] BAC were used to PCR-amplify this region from the indicated viruses. The HCMV[TRS1-S2H] and HCMV[TRS1-Mut1] products are 0.23 kb larger than TRS1
from AD169 due to sequences encoding the epitope tags. Ampliﬁcation of HCMV[ΔI/ΔT] DNA revealed the expected TRS1 deletion. (c) HF-TRS1 cell lysates were made at
72 hpi with the indicated viruses (MOI¼3). Immunoblot assays were performed with an antibody to the dsRNA-binding domain shared by TRS1 and IRS1. * indicates IRS1
expressed from AD169.
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During infection of HF with HCMV[ΔI/ΔT], the abundance of
phosphorylated eIF2α increases and protein synthesis levels are
reduced, suggesting that the failure of HCMV[ΔI/ΔT] to replicate is
due to the inability of this virus to block PKR activation (Marshall
et al., 2009). To evaluate the impact of the inability of HCMV[TRS1-
Mut 1] to bind to PKR on activation of the PKR pathway, we
infected HF with HCMV[TRS1-Mut 1] or control viruses at an MOI
of 3, collected lysates at 48 hpi, and evaluated the levels of phos-
phorylated and total PKR and eIF2α by immunoblot assays.
While infection with AD169 resulted in a very low amount of
phosphorylated PKR, similar to the level detected in mock-infected
cells, infection with either of two viruses that express TRS1 but not
IRS1 (HCMV[TRS1-HA] or HCMV[TRS1-S2H]) resulted in a small
increase of phospho-PKR compared to mock- and AD169-infected
cells. In contrast, considerably more phospho-PKR accumulated
after infection with either HCMV[TRS1-Mut 1] or HCMV[ΔI/ΔT]
(Fig. 5b). In addition, the amount of total PKR was markedlyreduced after infection with HCMV[TRS1-Mut 1] or HCMV[ΔI/ΔT].
This observation might reﬂect a reduction in PKR expression fol-
lowing HCMV[TRS1-Mut 1] and HCMV[ΔI/ΔT] infection due to the
shutoff of protein synthesis that occurs following PKR activation,
as has been observed in other systems (Bierle et al., 2012; Child et
al., 2012; Rothenburg et al., 2009).
Analyses of eIF2α in these same lysates revealed an increase in
phosphorylated eIF2α during infection with HCMV[TRS1-Mut 1] or
HCMV[ΔI/ΔT] compared to mock infection or infection with
AD169, HCMV[TRS1-HA] or HCMV[TRS1-S2H] (Fig. 5b, compare
lanes 4 and 5 to lanes 1 and 6). We also detected a decrease in the
amount of total eIF2α, similar to that observed for total PKR, again
suggesting an effect of shutoff of translation in cells in which TRS1
was absent or unable to block the PKR pathway. Cells infected with
either of the two viruses that express TRS1 but not IRS1 caused an
intermediate level of phosphorylated eIF2α to accumulate, but did
not show any reduction in total eIF2α. These results are consistent
with moderate but incomplete inhibition of PKR pathway activa-
tion by these viruses.
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activated during infection with HCMV[TRS1-Mut 1] just as it is
following infection with HCMV[ΔI/ΔT]. Therefore, TRS1-Mut
1 appears to be unable to prevent PKR activation during HCMV
infection, supporting the hypothesis that blocking PKR activation
is an essential function of TRS1.
PKR knockdown restores HCMV[ΔI/ΔT] replication
The above data conﬁrm that PKR antagonism is likely critical
for HCMV replication, but do not exclude the possibility that
additional TRS1 functions are also essential. To explore this pos-
sibility, we next tested the ability of HCMV[ΔI/ΔT] to replicate in
cells deﬁcient in PKR expression.
First, we used an shRNA directed against PKR to knock down
expression in primary HF. This PKR-kd cell line expressed much
less PKR than cells containing a control shRNA as can be seen by
immunoblot analysis (Fig. 6a, lanes 1 and 2). As well, VVΔE3L
replication was signiﬁcantly increased in the knockdown cells,
indicating a reduction in PKR-mediated inhibition (Fig. 6b), as has
been reported in other cell types (Child et al., 2012; Zhang et al.,
2008).
We next infected the PKR-kd cells with AD169, HCMV[TRS1-
S2H], and HCMV[ΔI/ΔT] to determine whether reduced PKRexpression was sufﬁcient to rescue HCMV lacking both TRS1 and
IRS1. We quantiﬁed the amount of virus present in the medium
after infection by titering the viruses on HF-TRS1. Replication of
AD169 and HCMV[TRS1-S2H] in the PKR-kd cells was 10-fold
lower than in Ctrl-kd cells, but this modest difference was not
always observed in other experiments and in other PKR deﬁcient
cells (see below). However, HCMV[ΔI/ΔT] was consistently able to
replicate only in the PKR-kd cells (Fig. 7). At 6 days post-infection,
HCMV[ΔI/ΔT] titers in the PKR-kd cells were one to two logs
lower than those of AD169 or HCMV[TRS1-S2H]. This could indi-
cate that TRS1 might provide one or more auxiliary functions that
aid replication. Alternatively, this reduction in HCMV[ΔI/ΔT] titer
might simply be due to an inhibitory effect of the small amount of
residual PKR remaining in these cells. Regardless, these data
demonstrate that PKR antagonism is the only function of TRS1 that
is essential for HCMV replication in HF.
PKR knockout restores replication of HCMV[ΔI/ΔT] and HCMV[TRS1-
Mut 1]
To determine whether the reduced replication of HCMV[ΔI/
ΔT] compared to AD169 and HCMV[TRS1-S2H] in the PKR
knockdown cells might be due to the presence of residual PKR, we
generated two independent PKR knockout cell lines using CRISPR/
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J.E. Braggin et al. / Virology 489 (2016) 75–8580Cas9 technology. The ﬁrst cell line (PKR KO A) contained disruptive
mutations adjacent to a splice acceptor site in both alleles, as
described in Materials and methods. The second cell line (PKR KO
B) targeted the ﬁrst double-stranded RNA binding domain in PKR.
In this case, the cells contained a single nucleotide insertion in
both alleles that resulted in a frameshift mutation.
PKR was expressed in vector-matched control cells but was
undetectable in PKR KO A or PKR KO B cells (Fig. 6a, lanes 3–6).
Additionally, when these cells were infected with VVΔE3L, the
virus replicated to a much higher level in both KO lines than in
control cells (Fig. 6b), and we were not able to detect any
phospho-PKR (data not shown), conﬁrming the reduction in PKR
expression.
We next evaluated the impact of PKR knockout on the repli-
cation of AD169 and the HCMV recombinants. Both PKR KO lines
and their paired control cells were infected with HCMV[TRS1-
S2H], HCMV[TRS1-Mut 1], or HCMV[ΔI/ΔT] at an MOI of 0.1 and
the amount of progeny virus in supernatants was determined by
titering on HF-TRS1. As expected, HCMV[TRS1-S2H] replicated well
and both HCMV[TRS1-Mut 1] and HCMV[ΔI/ΔT] failed to replicate
in control cells (Fig. 8). In contrast, both of these viruses replicated
as well as HCMV[TRS1-S2H] in each knockout cell line, again
conﬁrming that TRS1 is required to block the PKR pathway. This
result also suggests that any ancillary functions performed by TRS1
are unnecessary and do not contribute substantially to viral
replication in this system (Fig. 8).Discussion
HCMV replication depends on either TRS1 or IRS1 (Marshall et
al., 2009). While each of these proteins have been reported to have
multiple functions, which of these are essential for replication of
HCMV remained unknown prior to this study. TRS1 and IRS1 are
partially encoded within the repeats surrounding the unique short
region of the genome and thus their N-terminal two-thirds are
identical. In addition, their C-termini are 50% conserved. Thus, it
is not surprising that they share several reported activities,
including inhibition of autophagy and of the PKR and RNase L
pathways (Chaumorcel et al., 2012; Child et al., 2004; Mouna et al.,
2015). Both TRS1 and IRS1 are able to bind to dsRNA, PKR, and
Beclin-1 (Chaumorcel et al., 2012; Hakki and Geballe, 2005; Hakki
et al., 2006; Mouna et al., 2015). Also, TRS1 has been reported to
play a role in virion assembly and to bind the HCMV DNA pro-
cessivity factor UL44 as well as binding to the 7-methylguanosine
mRNA cap (Adamo et al., 2004; Blankenship and Shenk, 2002;
Strang et al., 2010; Ziehr et al., 2015). IRS1 encodes a second
smaller protein, IRS1263, which was reported to be a transcrip-
tional repressor (Romanowski and Shenk, 1997). Moreover, these
genes may have additional, as yet unknown, activities that could
be necessary for replication.
In this study we provide strong evidence, based on analyses of
mutant viruses and cell lines, that the sole essential function of
TRS1 and IRS1 during infection of cultured HF is the ability to
inhibit the PKR pathway. We generated a TRS1 mutant, TRS1-Mut
1, that is unable to bind to PKR. This mutant could not rescue
VVΔE3L replication and, importantly, when inserted into HCMV
[ΔI/ΔT], was incapable of rescuing HCMV replication. In contrast,
either of two wild-type TRS1 genes (TRS1-HA or TRS1-S2H) or the
major PKR antagonist from vaccinia virus (E3L, which also binds to
PKR), expressed from the same virus backbone could each rescue
viral replication (Marshall et al., 2009). These results suggest that
TRS1 needs to interact directly with PKR to inhibit PKR activation.
However, in a prior study, we identiﬁed a mutant that does not
bind to dsRNA or rescue VVΔE3L replication, yet does bind to PKR
((Bierle et al., 2013) and Fig. 2b and c). Thus, PKR binding appears
to be necessary but not sufﬁcient for TRS1 to block PKR activation.
These results suggest a model in which TRS1 heterodimerizes with
PKR in a complex that depends on the ability of TRS1 to bind to
both PKR and dsRNA, thereby preventing PKR homodimerization
and activation.
Although these results are consistent with the conclusion that
the essential role of TRS1 is to block the PKR pathway, it
remained possible that another function of TRS1 that might be
necessary for HCMV replication could have been disrupted by
the mutations introduced into TRS1-Mut 1. In order to address
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knockout cell lines. Our ﬁnding that HCMV[ΔI/ΔT] was able to
replicate in each of these PKR deﬁcient cell lines but not in
control lines demonstrates that the only essential function of
TRS1 (or IRS1) is PKR antagonism.
Like HCMV, many other viruses contain one or more genes that
target the PKR pathway in order to enable viral replication (Mohr
et al., 2007). Mouse cytomegalovirus (MCMV) m142 and m143 act
together to block PKR (Child et al., 2006; Valchanova et al., 2006).
Deletion of either gene abolishes MCMV replication and results in
PKR pathway activation in wild type MEFs, but MCMV lacking both
genes replicates as well as wild-type MCMV in PKR-null MEFs
(Budt et al., 2009). Moreover, viruses lacking either m142 or m143
fail to replicate in wild-type mice but replicate to levels similar to
wild-type MCMV in PKR-null mice (Ostermann et al., 2015), indi-
cating that the only apparent role for m142 and m143 is to block
the PKR pathway. VVΔE3L is incapable of replicating in many cell
types and is avirulent in wild-type mice, but its replication is at
least partially restored in PKR-deﬁcient cells and mice (Brandt and
Jacobs, 2001; Rice et al., 2011). Similarly, the reduced neuroviru-
lence of herpes simplex virus 1 lacking ICP34.5 in wild-type mice
is restored in PKR-null mice (Leib et al., 2000). Vaccinia virus and
herpes simplex virus 1 each contain at least one additional PKR
antagonist, K3L and US11, respectively, that might account for the
ability of the ΔE3L and ΔICP34.5 viruses to replicate in some
settings (Langland and Jacobs, 2002; Mulvey et al., 2004). These
examples highlight the critical contribution of PKR antagonism to
viral replication in multiple viral systems.
Our studies also reveal insights into why HCMV might have
retained two seemingly redundant PKR antagonists. Although
other reports have indicated that deletion of just IRS1 does not
impact replication, we have observed a mild reduction in the
replication of two different viruses that lack IRS1, HCMV[TRS1-HA]
and HCMV[TRS1-S2H] ((Marshall et al., 2009) and Fig. 5a). More-
over, infection with these viruses results in an increased level of
phospho-PKR compared to cells infected with wild-type HCMV
(Fig. 5b). Although it is possible that the epitope tags weaken
TRS1’s ability to block PKR in these viruses, our data suggest the
possibility that TRS1 alone is not as efﬁcient at blocking PKR as are
TRS1 and IRS1 in combination. In studies involving experimental
evolution of vaccinia virus recombinants, we found that gene
ampliﬁcation of a weak PKR antagonist led to improved viral
replication (Brennan et al., 2014; Elde et al., 2012). In the same
way, it is possible that deletion of TRS1 or IRS1 leads to a reduction
in the total level of PKR antagonism during HCMV replication.
Some data suggest that wild-type HCMV expresses more TRS1
than IRS1 (Bierle et al., 2013; Mouna et al., 2015), which may
explain the replication defect observed in single deletion mutants
of TRS1 but not IRS1 (Blankenship and Shenk, 2002; Dunn et al.,
2003; Jones and Muzithras, 1992). It is possible that simultaneous
expression of both proteins might be necessary in order to gen-
erate an optimal concentration of TRS1 and IRS1 to block PKR.
Our ﬁnding that PKR antagonism is the only essential function
of TRS1 and IRS1 raises questions about the importance of the
other activities that have been attributed to these factors. Some of
those functions may be indirect consequences of their ability to
block PKR activation. For example, the described activation of
reporter gene expression might simply be due to maintenance of
protein synthesis as a result of TRS1 or IRS1 blocking PKR. Con-
sistent with this interpretation, we found that TRS1 did not acti-
vate reporter gene expression in PKR-deﬁcient cells (Bierle et al.,
2012). Ziehr et al found that most but not all of the increase in
reporter gene expression by TRS1 was eliminated by PKR deple-
tion (Ziehr et al., 2015). Their study implicated a PKR-independent
effect of TRS1 on translation that might be mediated by the ability
of TRS1 to bind to the mRNA cap. Likewise, TRS1’s reported role invirion formation might be a secondary consequence of the effects
of TRS1 on translation of factors needed for assembly. We pre-
viously reported that TRS1 and IRS1 are able to prevent activation
of the OAS/RNaseL pathway in the setting of VVΔE3L infection
(Child et al., 2004). However, infection with HCMV[ΔI/ΔT] did not
activate this pathway (Marshall et al., 2009), possibly because PKR
activation represses viral replication prior to accumulation of
sufﬁciently high levels of dsRNA to activate OAS/RNaseL. Regard-
less, the ﬁnding that HCMV[ΔI/ΔT] replicates in PKR-deﬁcient
cells demonstrates that antagonism of the RNaseL pathway is not
an essential function of TRS1 or IRS1.
In contrast to reported activities that might simply result from
maintenance of translation, the inhibition of autophagy by TRS1
and IRS1 cannot be explained by antagonism of PKR (Chaumorcel
et al., 2012; Mouna et al., 2015). These activities map to separate
domains of the proteins. While PKR inhibition requires the C-
terminus of TRS1 and IRS1, this domain is not necessary for
Beclin-1 binding or blocking autophagy. Conversely, the N-
terminal 44 codons of both proteins are required to block
autophagy efﬁciently but not to inhibit PKR. In addition, TRS1
blocks autophagy even in PKR-null cells. Finally, some data show
that autophagy induction may aid, rather than inhibit, HCMV
replication (Mouna et al., 2015; Zhao et al., 2013), but another
report suggests the reverse effect (Belzile et al., 2015). Regardless,
our data indicate that inhibition of autophagy is not an essential
function of TRS1 or IRS1.
Our results reveal that inhibition of PKR is the single essential
function of TRS1 or IRS1, at least in cultured HF infected with
HCMV AD169. Indeed, the observation that HCMV[ΔI/ΔT] repli-
cates as well as wild-type virus in PKR-null cells suggests that
TRS1’s other activities contribute little to productive HCMV repli-
cation in cell culture. Although it remains possible that other
functions of TRS1 and IRS1 might have an important or even
essential role in other cell types or in natural HCMV infection,
these studies highlight the importance of PKR as a strong viral
restriction factor that has compelled many viruses to evolve
effective evasion strategies.Materials and methods
Cells
All cells were maintained at 37 °C in Dulbecco's modiﬁed
Eagle's medium supplemented with 10% NuSerum. Primary
human foreskin ﬁbroblasts (HF) and telomerase-immortalized HF
(HF-Tert) were provided by Denise Galloway (Fred Hutchinson
Cancer Center). HF transduced with a TRS1-expressing retrovirus
(HF-TRS1) were reported previously (Marshall et al., 2009).
PKR knockdown and control knockdown HF were created by
transduction with lentiviral vectors expressing either an shRNA
targeting PKR or a control shRNA (Open Biosystems, catalog
numbers RHS4430-98844125 and RHS4346, respectively) followed
by selection in puromycin (1 μg/ml).
PKR knockout A (PKR KO A) cells were constructed by trans-
ducing HF-Tert cells with a lentiviral vector that expresses Cas9
(Eckard et al., 2014) and a guide RNA (gRNA) with the genomic
target sequence 50-TCTCTTCCATTGTAGGATA-30 (kindly provided
by Elizabeth Gray and Dan Stetson, University of Washington).
The predicted Cas9 cleavage site (between the two underlined
nucleotides) is 1 bp downstream of the conserved AG (bold) of the
exon 3 splice-acceptor site and 15 bp upstream of the PKR initia-
tion codon. Following puromycin selection, single-cell clones were
isolated and analyzed by PCR-amplifying this region of genomic
DNA using primers #2001 and #2030 (Table 1), followed by TOPO-
cloning and sequencing of multiple inserts from each of several
Table 1
Oligonucleotide primers.
Primer # 50 to 30 sequence
622 CTCGAGACCATGGGCGTGGGCACCCCGCGC
783 GCCTCTAACATTGAGACAGCATA
841 GGTTCTGCAGCTTCACCTGGTAACCTTGGTGGTTTCCAATCTTC
876 GTTACCGAATTCGCGGCCGCCCATCATCACCATCACCATTAACTGCA
877 GTTAATGGTGATGGTGATGATGGGCGGCCGCGAATTCG
878 GCGCGGCCGCATCAATTTCCAAACCACATCTC
879 GCGCGGCCGCACAACCTTTTGGAACAGTTGG
881 GCGCGGCCGCTTGAGCGTTGTAATGGTAATG
917 GCGCGGCCGCATCCAAATCATACCAAGAATCTTCACC
918 GCGCGGCCGCCTTTCTATTAGAACCCAAAACCCAAAAAG
919 GCGCGGCCGCTTTCTTCCATCTTCTTTGATAAACATCG
1052 TCGAGCTGGAGCCACCCCCAGTTCGAGAAGGGCGGCGGCAGCGGCGGCGGCAGCGGCGGCGGCAGCTGGAGCCACCCCCAGTTCGAGAAGGGT
1053 CTAGACCCTTCTCGAACTGGGGGTGGCTCCAGCTGCCGCCGCCGCTGCCGCCGCCGCTGCCGCCGCCCTTCTCGAACTGGGGGTGGCTCCAGC
1096 ACGTGCTTTGGCCCGGGCCGCCGCCGATTGGAAACCGCCACGTCT
1097 GTTTCCAATCGGCGGCGGCCCGGGCCAAAGCACGTCCCAAACTGG
1098 CGACGGGACGCCGCCGATTGGGCCCCGCCACGTCTCCCTGGGGA
1099 GACGTGGCGGGGCCCAATCGGCGGCGTCCCGTCGCAAAGCACGT
1100 CTCCCTGGGGCCGCCTCCTGGTACGACTTGGACG
1101 GTACCAGGAGGCGGCCCCAGGGAGACGTGGCGGT
1102 TCCTGGTACGCCTTGGCCGCCACTTTCTGGGTTCTGGGGAG
1103 CCCAGAAAGTGGCGGCCAAGGCGTACCAGGAGTCTTCCCCA
1104 GGGGAGTAACGCCAAAAACGCCGTGTATCAACGACGTTGGA
1105 TTGATACACGGCGTTTTTGGCGTTACTCCCCAGAACCCAGA
1106 AACCGTGTTAGCCTGTGGTTTGGCCATTGATCGTCCCATGCCAAC
1107 GACGATCAATGGCCAAACCACAGGCTAACACGGTTTTCTTCCAAC
1108 TGTGGTTTGGCCATTGCCGCCCCCATGCCAACGGTCCCCAA
1109 TTGGCATGGGGGCGGCAATGGCCAAACCACAGCGTAACACG
1170 CGAGGCTGATCAGCGGGTTTTACGAGGACAGGCTGGAGC
1171 TCACCATCACCATTGAGTTTGACGACGACGACAAGTAAGAAG
1185 TTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGGTTTTAGAGCTAG
1186 GACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAACCGGTGTTTCGTCCT
1187 TTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGTTCAGGACCTCCACATGAT
1188 GACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAACATCATGTGGAGGTCCTGAAC
1197 TAGTTAAGCTTGGTACCGAGCTCGTGACGCGGGTTTGCTTCCTATATAGTGGACGTCGGA
1198 CTGGGCCATGGCCGCCGGACGGATCCGGGCGCCGGACACCTCCGACGTCCACTATATAGG
1199 CTAGAAAGTATAGGAACTTCGAATTCACTGGTTTTCTTTTGCAGCTGTCGTTATGTTTCG
2000 GCTGGAGCCATGGCTGGTGACCTTGTAAAACAAGTTTTCGAAACATAACGACAGCTGCAA
2001 ATATGTTCTGTGAGCATCACTC
2030 GACCTCCACATGATAGGAG
2049 GCTACCACTCCACTTCACTTATT
2050 AGGCAATCACTCACCTTCTTT
2180 ATATGAAGCGTCGCGAGTATTA
2183 GCACGTCGCTGCCTATAAA
BGH rev. TAGAAGGCACAGTCGAGG
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homologous end joining resulting from cleavage at the expected
site. In some cases, the resulting alleles retained the splice site and
did not contain any large deletions. These clones expressed PKR as
determined by immunoblot assays and were nonpermissive for
VVΔE3L replication (data not shown). Other clones had alleles
with mutations that removed the splice acceptor site and/or the
PKR initiation codon. Analyses of PKR KO A revealed that this clone
had one PKR allele with a 3 bp deletion that inactivated the splice
acceptor site and a second allele with both a 66 bp deletion and a
7 bp duplication that deleted the PKR initiation codon. A control
clone (Cas9 Ctrl A) was constructed by transducing HF-Tert with a
similar vector that did not contain a gRNA. Sequence analyses of
the PKR locus in this clone revealed the wild-type genomic
sequence.
We constructed another PKR KO cell line (PKR KO B) by
transducing HF with a construct containing doxycycline-inducible
Cas9 and a gRNA targeting the ﬁrst dsRNA-binding domain of PKR
(pEQ1510; target sequence 50-TTCAGGACCTCCACATGAT-30; Cas9 is
predicted to cut between the two underlined nucleotides). Fol-
lowing puromycin selection (1 mg/ml), Cas9 expression was
induced by addition of 1 μg/ml doxycycline for a minimum of twoweeks prior to analysis. Screening of this cell line as described
above (using primers #2049 and #2050 for PCR ampliﬁcation)
showed only a single bp insertion at the predicted cut site.Plasmids
We made a series of C-terminal truncations in TRS1 for use in
yeast two-hybrid assays. We ﬁrst introduced a silent mutation to
create a BstEII site within TRS1 by PCR-amplifying pEQ1284 (Child
et al., 2012) with primers #783 and #841 (Table 1). The amplicon
was digested with BglII and PstI and inserted into those same sites
in pEQ1284, resulting in pEQ1304. We then annealed primers
#876 and #877 and ligated the product into the BstEII and PstI
sites of pEQ1304, generating pEQ1331, which added EcoRI and NotI
sites and a 6XHis tag to the C-terminus of TRS1[1-667]. For each
additional 30 truncation, we PCR-ampliﬁed pEQ1284 with forward
primer #783 and the following reverse primers, digested the
product with BglII and NotI, and inserted it into the BglII and NotI
sites of pEQ1331. Reverse primer #917 was used for pEQ1360
(TRS1[1-679]); primer #918 for pEQ1361 (TRS1[1-690]); primer
#919 for pEQ1362 (TRS1[1-700]; Primer #878 for pEQ1340 (TRS1
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#881 for pEQ1342 (full length TRS1[1-795]).
To make plasmids for use in transfection assays, primers #1052
and #1053, containing sequences encoding a TwinStrep tag, were
annealed and ligated into pEQ1180 (Child et al., 2012) that had
been digested with XhoI and XbaI to generate pEQ1435, a plasmid
that expresses full length TRS1 with TwinStrep and 6XHis tags.
The same primers inserted into an EGFP-6XHis expression plasmid
derived from pEQ1100 (Child et al., 2006) to generate pEQ1436.
TRS1 was excised from pEQ1427, which expresses a triple mutant
of TRS1 that does not bind to dsRNA (Bierle et al., 2013) and from
pEQ978 (Hakki and Geballe, 2005), which contains a C-terminal
truncation (TRS1[1-648]) using HindIII and XhoI and the frag-
ments were cloned into the same sites in pEQ1435 to generate
pEQ1442 and pEQ1445, respectively. A plasmid expressing kinase-
dead PKR with a biotinylation signal and 6XHis tag (pEQ1232) was
constructed by transferring PKR from pEQ1198 (Child et al., 2012)
into the pSV2 vector backbone and then cloning in the biotinyla-
tion signal from pEQ1068 (Child and Geballe, 2009). To design
charged-cluster-to-alanine mutants of TRS1, we aligned TRS1 and
IRS1 sequences from HCMV Towne (Accession # FJ616285) and
Chimpanzee CMV strain Heberling (Accession # NC_003521) using
ClustalX 2.1. To introduce these mutations, TRS1 was ampliﬁed in
two separate reactions, the ﬁrst using a common upstream primer
(#622) along with a mutant reverse primer (Table 1) and the
second using a mutant forward primer and a common reverse
primer (BGH). Subsequently, stitch PCR was used to join each set of
products using the #622 and BGH reverse primers. The ﬁnal PCR
products were digested with PpuMI and XhoI and cloned into the
same sites in pEQ1445. The speciﬁc mutant forward and reverse
primer pairs were as follows: pEQ1468 (Mut 1) used #1096 and
#1097, pEQ1469 (Mut 2) used #1098 and #1099, pEQ1470 (Mut 3)
used #1100 and #1101, pEQ1471 (Mut 4) used #1102 and #1103,
pEQ1472 (Mut 5) used #1104 and #1105, pEQ1473 (Mut 6) used
#1106 and #1107, and pEQ1474 (Mut 7) used #1108 and #1109.
The amino acids that were mutated to alanine in each of these
constructs are indicated in Fig. 2a.
To construct pEQ1510, the 2 kb ﬁller sequences in lentiCRISPR
((Shalem et al., 2014) a gift from Feng Zhang, Addgene plasmid #
49535) were removed by BsmBI digestion, followed by the intro-
duction of a pair of annealed primers that contain an AgeI
restriction site (#1185 and #1186) using Gibson Assembly (New
England Biolabs). A NotI to XhoI fragment was then excised and
cloned into pCW-Cas9 ((Wang et al., 2014), a gift from Eric Lander
and David Sabatini, Addgene plasmid # 50661) cut with the same
enzymes. This yielded a lentiviral vector expressing tet-inducible
Cas9 and containing the U6 promoter, an AgeI site into which
different gRNAs can be introduced and the gRNA scaffold. The
resulting vector, pEQ1508, was then digested with AgeI, and
paired, annealed primers designed to target the ﬁrst dsRBD of PKR
(#1187 and #1188) were introduced by Gibson Assembly.
To construct plasmids for recombination into bacterial artiﬁcial
chromosomes (BACs), a FRT-Kan-FRT cassette, PCR ampliﬁed from
pSLFRTkn (Atalay et al., 2002) using primers #1170 and #1171, was
cloned into the PmeI site of pcDNA3.1-V5-His-TOPO vectors con-
taining TwinStrep-tagged wild-type TRS1 (pEQ1435) or TRS1-Mut
1 (pEQ1468) by Gibson assembly. The plasmids were digested with
BamHI, then paired, annealed oligonucleotides containing the
upstream 50 bp homology arm (#1197 and #1198) were intro-
duced by Gibson Assembly. The resulting vectors were then
digested with EcoR1 and BstEII, and paired, annealed primers
#1199 and #2000 containing the downstream 50 bp homology
arm were inserted by Gibson Assembly to yield pEQ1521 (HCMV
[TRS1-S2H]) and pEQ1524 (HCMV[TRS1-Mut 1]).Yeast two-hybrid assay
Yeast two-hybrid assays were conducted as previously descri-
bed using a yeast codon-optimized variant of TRS1 fused to the
GAL4 DNA binding domain and kinase-dead PKR fused to the GAL4
transcriptional activation domain in yeast expression vectors
(Child et al., 2012).
Pulldown assays
For the PKR pulldown assays, COS7 cells were transfected with
TwinStrep and 6XHis-tagged (-S2H) TRS1 constructs and a Biotin
and 6XHis-tagged, kinase-dead form of human PKR (PKR-BH,
pEQ1232), using Lipofectamine 2000 (Invitrogen). At 48 h post-
transfection, the cells were pelleted at 2000g for 5 min at 4 °C and
washed with cold PBS. The cell pellet was resuspended in 150 μl of
lysis buffer (50 mM Tris HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA,
0.5% NP-40, with freshly added 1 μM each of NaVO4, homo-
arginine, and benzamidine and 100 μM PMSF) at 4 °C and incu-
bated on ice for 20 min, with periodic vortexing. Nuclei were
removed by centrifugation at 10,000g for 10 min at 4 °C. 5 μl per
sample was saved on ice as the input and the remaining 145 μl
was used for the pulldown. A 1:6.5 mixture of Streptactin beads
(IBA Lifesciences; Schmidt 2013) and Sepharose CL-B6 beads
(Sigma) was washed twice with lysis buffer and resuspended in
600 μl lysis buffer. The lysates were added to the bead mixture and
incubated on a rotator at 4 °C for 2 h. The beads were pelleted and
washed three times with lysis buffer and twice with wash buffer
(lysis buffer without the protease inhibitors and NP-40). Proteins
were eluted from the beads by heating to 95 °C in loading buffer
and separated by SDS-PAGE.
For the dsRNA pulldown, 293T cells were transfected with
TRS1-expressing plasmids using Lipofectamine 2000 (Invitrogen)
and lysates were harvested at 48 h post-transfection. The dsRNA-
binding assay was performed as previously described (Bierle et al.,
2013).
VVΔE3L rescue assays
HeLa cells were transfected in triplicate with expression plas-
mids using Lipofectamine 2000 (Invitrogen). After 48 h, the cells
were infected (MOI¼0.1) with VVΔE3L, a vaccinia virus mutant in
which E3L has been replaced with a LacZ cassette (provided by
Bertram Jacobs). At 48 h post-infection (hpi), VVΔE3L replication
was monitored by quantiﬁcation of β-galactosidase activity by a
ﬂuorometric substrate cleavage assay essentially as has been
described (Hakki and Geballe, 2005). VVΔE3L replication in PKR
knockdown and knockout cell lines was assessed at 48 hpi
(MOI¼0.1).
BAC recombineering
After digestion of pEQ1521 (wild-type TRS1) and pEQ1524
(TRS1-Mut 1) with Asp718 and BstEII, the TRS1-FRT-kan-FRT
fragments were transformed into Escherichia coli EL250 contain-
ing an HCMV BAC lacking both IRS1 and TRS1 (HCMV[ΔI/ΔT]
(Marshall et al., 2009)). Following selection of kanamycin-resistant
colonies, the kanR gene was removed by arabinose induction of
FLP recombinase followed by selection for kan-sensitive colonies.
BAC DNAs were analyzed by digestion with EcoRI, BamHI, or
HindIII followed by electrophoresis on 0.7% agarose gels and
ethidium bromide staining.
To reconstitute viruses, BAC DNA was puriﬁed from E. coli using
the NucleoBond BAC 100 kit (Clontech) and transfected along with
the cre-expression plasmid pBRep-Cre into HF-TRS1 using Lipo-
fectamine LTX reagent (Life Technologies). Mutant viruses were
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was harvested from infected PKR KO cells by lysis with 2% SDS,
proteinase K digestion, phenol:chloroform extraction and ethanol
precipitation. The resulting DNAs were analyzed by PCR with
primers located upstream (#2183) and downstream (#2180) of
TRS1 and outside of the homologous recombination arms. The PCR
products were sequenced with multiple forward and reverse pri-
mers, which yielded sequence covering the ﬂanking regions and a
minimum of 800 bp within both the 50 and 30 ends of TRS1. These
results conﬁrmed the identities of the wild-type and mutant TRS1
genes as well as their proper localization in the viral genome.
Immunoblot analyses
With the exception of pulldown assays (above), lysates for
immunoblot assays were prepared by washing the monolayer with
phosphate-buffered saline and lysing the cells with 2% SDS. After
sonication to disrupt the cellular DNA, proteins were separated by
10% SDS-PAGE, transferred to a PVDF membrane (Millipore), and
probed with the indicated antibodies using the Western Star
chemiluminescent detection system (Applied Biosystems).
Antibodies used in these experiments include eIF2α L57A5
(#2103), phospho-eIF2α Ser51 (#3597), and PKR D7F7 (#12297),
all from Cell Signaling Technology, PKR B-10 (sc6282, Santa Cruz
Biotechnology), Penta-His (Qiagen), phospho-PKR T446 (ab32026,
AbCam), and Actin (A2066, Sigma). Rabbit antiserum that recog-
nizes the TRS1/IRS1 dsRNA binding domain (anti-p999) has been
described previously (Marshall et al., 2009).Acknowlegdements
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